COMMUNIQUÉS West-GlobeNewswire

-
Greystone Health Network Acquires The Ponce Therapy Care Center in St. Augustine
03/06/2019 -
Emerald Health Therapeutics participera à des conférences sur l'investissement et l'industrie en juin
03/06/2019 -
Wildflower Reports 78% Sales Growth in Third Quarter
03/06/2019 -
Ceapro Inc. Commences Patient Enrollment in First-in-Human Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent
03/06/2019 -
White-Labeled Version of iSage Rx launched in Brazil in collaboration with Novo Nordisk
03/06/2019 -
Aptose Appoints Jotin Marango, M.D., Ph.D. as Chief Business Officer
03/06/2019 -
Interim Data for CPI-0610 in MANIFEST Clinical Trial Showed Signals of Clinical Activity in Myelofibrosis Patients
03/06/2019 -
AXIM® Biotechnologies, Inc. Signs Cannabinoid Product Supply Agreement with Healthcare Company for Clinical Trials on Treatment of Periodontitis
03/06/2019 -
Generex Biotechnology Announces Date for Rescheduled May 15th Investor Conference Call to Present Organizational Roadmap & Update on Investor Dividend, Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans
03/06/2019 -
Telix Pharmaceuticals to Present at Jefferies Healthcare Conference
03/06/2019 -
Vystar Contracts Rubber Expert Ranjit Matthan for Deproteinized Dry Rubber and Latex R&D
03/06/2019 -
Aptose Announces Closing of Public Offering of Common Shares
03/06/2019 -
Progenics Announces Updated Survival Data for AZEDRA® (iobenguane I 131) in Advanced Pheochromocytoma and Paraganglioma
03/06/2019 -
Aeglea BioTherapeutics Doses First Patient in Pivotal Phase 3 PEACE Trial of Pegzilarginase in Arginase 1 Deficiency
03/06/2019 -
Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research
03/06/2019 -
SELLAS Announces Immune Response Data in Triple Negative Breast Cancer Patients from Phase 2b Study of Nelipepimut-S (NPS) Plus Trastuzumab Presented at ASCO 2019
03/06/2019 -
Advantis Corporation Takes Major Step Toward OTC QB
03/06/2019 -
Merus to Present at the Jefferies 2019 Healthcare Conference
03/06/2019 -
Matinas BioPharma to Present at the 9th Annual LD Micro Invitational
03/06/2019
Pages